Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London 2019
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
Download 2018 Feedback Form (Required for Credits)
Pre-conference Presentations
2018 Program
2018 Speaker List & Presentation Download
Speaker Videos
2018 Pre-Conference Workshops
2018 Exhibitors
2018 Peer Review Board Members
Delegate Information
2018 VENUE: The Kensington Town Hall - MAP
Nearby London Accommodations
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
Past Conference Information
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  Past Speakers 2004
  Past Speakers Monte Carlo 2002
BSAAM's AACL Organizer
BSAAM Affiliates
AACL Supporters
HB Health
  Sun Chlorella
AACL 2017 Speaker
Christophe de Jaeger Professor Christophe de Jaeger

Unité de Physiologie de la sénescence - Institut Européen de la Longévité, Paris, France
Christophe de JAEGER is one of the founder of anti aging medicine in Europe. He started his career as a geriatrician and he is actually professor of medical physiology and a specialist of evaluation and the management of ageing in Paris, France. He teaches at the international university MTU in Paris. He is the author of many articles and several books on aging management. He is also Founder President of the European Institute of Longevity and the French society of longevity physiology and medicine. Christophe de JAEGER is also the funder and redactor in chief of the international review Medicine and Longevity. He is an international speaker, and his works focuses actually principally on physiological age and management. He is the head of the Health and Longevity Department (Institut de Jaeger).

2017 Lecture: Interest of Biological Age Measurement in Young Adult Population

By 2050, the world population aged 80 y and above will more than triple, approaching 400 million individuals. As the population ages, the global burden of disease and disability is rising. From the fifth decade of life, advancing age is associated with an exponential increase in burden from many different chronic conditions. The most effective means to reduce disease burden and control costs is to delay this progression by extending healthspan, years of life lived free of disease and disability. A key to extending healthspan is addressing the problem of aging itself.

Antiaging therapies show promise in model organism research. Translation to humans is needed to address the challenges of an aging global population. This shows the necessity of using bio markers to challenge the aging process. Interventions to slow human aging will need to be applied to still- young individuals. However, most human aging research examines older adults, many with chronic disease. As a result, little is known about aging in young humans.

We will discuss some methods by which aging can be measured in young adults. Longitudinal measure, per example, allows quantification of the pace of coordinated physiological deterioration across multiple organ systems (e.g., pulmonary, cardiovascular, renal, hepatic, immune function…). These methods can be used to assess biological aging in young humans who had not yet developed age-related diseases. We will show that young individuals of the same chronological age varied in their “biological aging” (declining integrity of multiple organ systems). Already, before midlife, individuals who were aging more rapidly were less physically able, showed cognitive decline and brain aging, self-reported worse health, and looked older. Measured biological aging in young adults can be used to identify causes of aging and evaluate rejuvenation therapies.

It is possible to quantify individual differences in aging in young humans. This development breaks through two blockades separating model organism research from human translational studies. One blockade is that animals age quickly enough that whole lifespans can be observed whereas, in humans, lifespan studies outlast the researchers. A second blockade is that humans are subject to a range of complex social and genomic exposures impossible to completely simulate in animal experiments. If aging can be measured in free-living humans early in their lifespans, there are new scientific opportunities. There are also potential clinical applications. Early identification of accelerated aging before chronic disease becomes established may offer opportunities for prevention. Above all, measures of aging in young humans allow for testing the effectiveness of antiaging therapies (e.g., caloric restriction) without waiting for participants to complete their lifespans.

Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :